Dementia News and Research

Latest Dementia News and Research

New program improves quality of care for people with cognitive impairment in low cost

The patient and caregiver-centered Aging Brain Care program, developed by researchers at the Regenstrief Institute and the Indiana University Center for Aging Research, is attracting nationwide interest for its ability to improve health outcomes and quality of care for those with cognitive impairment while dramatically lowering costs to patients and health care systems.

21 May 2014

Holistic exercise program may improve physical, psychological wellbeing of dementia patients

While dementia patients can often suffer from depression and declining physical and mental ability, exercise has been shown to help improve both their physical and psychological wellbeing.

20 May 2014

BRF expands study to evaluate whether structured exercise slows progression of AD

The Brain Research Foundation (BRF) today announced that it will provide a major grant that will further research funded by the National Institute of Aging (NIA) which evaluated whether structured exercise slows the progression of Alzheimer's disease.

15 May 2014

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

In 2008, researchers at the Perelman School of Medicine at the University of Pennsylvania showed that mutations in two proteins associated with familial Alzheimer's disease (FAD) disrupt the flow of calcium ions within neurons.

15 May 2014

Anti-depressants could slow onset of Alzheimer's disease

A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD).

15 May 2014

Mylan releases generic version of Zyprexa Zydis Tablets

Mylan Inc. today announced that it has launched Olanzapine Orally Disintegrating Tablets (ODT), 5 mg, 10 mg, 15 mg and 20 mg, the generic version of Eli Lilly and Company's Zyprexa Zydis Tablets.

14 May 2014

Scientists discover novel protein fragments that may protect against Alzheimer's disease

The devastating loss of memory and consciousness in Alzheimer's disease is caused by plaque accumulations and tangles in neurons, which kill brain cells.

14 May 2014

AFib patients who are on blood thinning medications are at higher risk of developing dementia

A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.

12 May 2014

People with longevity gene have improved brain skills

Scientists showed that people who have a variant of a longevity gene, called KLOTHO, have improved brain skills such as thinking, learning and memory regardless of their age, sex, or whether they have a genetic risk factor for Alzheimer's disease.

12 May 2014

Patients with Parkinson's disease show improvements after exenatide therapy

Follow-Up Study Published in the Journal of Parkinson's Disease Supports an Earlier "Proof of Concept" Trial. A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy.

9 May 2014

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen R&D Ireland Ltd. (Janssen) today announced that it has expanded its collaboration with the International Partnership for Microbicides (IPM) for the development and delivery of dapivirine (TMC120) for the prevention of HIV.

8 May 2014

Viewpoints: Evidence for Obamacare saving lives; a continuing role for Minnesotacare

People asking the ultimate question about the Affordable Care Act--will it actually save lives?--now have an answer, and it's yes.

8 May 2014

Study finds premature menopause associated with long-term negative effects on cognitive function

Premature menopause is associated with long-term negative effects on cognitive function, suggests a new study published today (7 May) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

8 May 2014

First Edition: May 6, 2014

Today's headlines include news from Massachusetts that the state is scrapping efforts to fix its troubled health exchange and will start over -- from scratch.

6 May 2014

Researchers discover potential genetic variant that may make brains more resilient against Alzheimer's

Autopsies have revealed that some individuals develop the cellular changes indicative of Alzheimer's disease without ever showing clinical symptoms in their lifetime.

5 May 2014

Mayo Clinic neuroscientists define subtype of Alzheimer's disease

Neuroscientists at Mayo Clinic in Florida have defined a subtype of Alzheimer's disease (AD) that they say is neither well recognized nor treated appropriately.

2 May 2014

Highly stressed people who eat lot of high-fat are more prone to health risks

New research out of UC San Francisco is the first to demonstrate that highly stressed people who eat a lot of high-fat, high-sugar food are more prone to health risks than low-stress people who eat the same amount of unhealthy food.

30 Apr 2014

Study finds that Medicare patients with dementia more likely to be readmitted within 30 days

A review of more than 25,000 admissions of Medicare beneficiaries to Rhode Island hospitals has found that patients with a documented diagnosis of dementia are nearly 20 percent more likely to be readmitted within 30 days than those without dementia.

30 Apr 2014

GE Healthcare announces commercial availability of new Alzheimer’s diagnostic tool

GE Healthcare today announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a radioactive diagnostic agent approved by the FDA will be available. Late in the second quarter of 2014, Vizamyl will be available to imaging centers near East Rutherford, NJ, Woburn, MA, Beltsville, MD, East Lansing, MI, Dallas, TX, Phoenix, AZ and Colton, CA.

29 Apr 2014

Bristol-Myers Squibb completes acquisition of iPierian

Bristol-Myers Squibb Company and iPierian, Inc. announced today that Bristol-Myers Squibb has acquired iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, a class of neurodegenerative diseases associated with the pathological aggregation of Tau protein in the human brain.

29 Apr 2014

Dementia News and Research

Latest Dementia News and Research

New program improves quality of care for people with cognitive impairment in low cost

Holistic exercise program may improve physical, psychological wellbeing of dementia patients

BRF expands study to evaluate whether structured exercise slows progression of AD

Suppressing hyperactivity of calcium channels alleviates familial Alzheimer's disease

Anti-depressants could slow onset of Alzheimer's disease

Mylan releases generic version of Zyprexa Zydis Tablets

Scientists discover novel protein fragments that may protect against Alzheimer's disease

AFib patients who are on blood thinning medications are at higher risk of developing dementia

People with longevity gene have improved brain skills

Patients with Parkinson's disease show improvements after exenatide therapy

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Viewpoints: Evidence for Obamacare saving lives; a continuing role for Minnesotacare

Study finds premature menopause associated with long-term negative effects on cognitive function

First Edition: May 6, 2014

Researchers discover potential genetic variant that may make brains more resilient against Alzheimer's

Mayo Clinic neuroscientists define subtype of Alzheimer's disease

Highly stressed people who eat lot of high-fat are more prone to health risks

Study finds that Medicare patients with dementia more likely to be readmitted within 30 days

GE Healthcare announces commercial availability of new Alzheimer’s diagnostic tool

Bristol-Myers Squibb completes acquisition of iPierian

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in